6505--442 NUCLEAR MEDICINE RADIOPHARMACEUTICALS

Statement of Work (SOW) / Performance Work Statement (PWS)

To provide recurring daily deliveries of Nuclear Medicine Radiopharmaceuticals to the Cheyenne VA Medical Center to support diagnostic imaging procedures.

• The Contractor shall manufacture and deliver radiopharmaceuticals on a recurring daily basis as ordered.

• Deliveries must support all Nuclear Medicine procedures and comply with all applicable regulatory safety and security requirements.

• The Contractor is responsible for providing all personnel, equipment, facilities, materials, supplies, licenses, and transportation.

• Deliveries must arrive within a timeframe that preserves radiopharmaceutical integrity based on half-life requirements.

• All radiopharmaceuticals must meet U.S. Pharmacopeia (USP) specifications for strength, purity, sterility, and radiochemical identity.

• Dose calibrations must be accurate and documented.

• Any deviation affecting patient safety or image quality must be immediately reported to the Contracting Officer Representative (COR).

• Contractor must maintain all required licensure and provide documentation upon request.

• Contractor must have procedures for reporting damaged, leaking, or compromised shipments and notify the COR of any NRC-reportable events.

• Place of Performance: Cheyenne VA Medical Center, Diagnostic Imaging (Radiology), 2360 E Pershing Blvd, Cheyenne, WY 82001.

• Deliveries are recurring daily.

• Ordering & Delivery: Daily orders placed by COR. Deliveries must go directly to an authorized user or licensed nuclear pharmacist, not general receiving. Delivery personnel must comply with VA security and radiation safety requirements.

• Packaging & Transport: Must meet NRC and DOT requirements for radioactive materials, including appropriate shielding, labeling, and exposure rate limits. Chain-of-custody procedures are required.

• Required Radiopharmaceuticals: Includes categories such as Xe133, MAA Kits, Mebrofenin Kits, Medronate Kits, Sodium Pertechnetate Tc-99m, I-123 Capsules, and various Tc-99m labeled products. Also includes delivery charges, calibration sources, and syringe shields.

• Government Furnished Property: None.

• Invoicing: Submit electronically via Tungsten/VA FSC system, including contract number, date, product details, pricing, and delivery confirmation. Invoices must match delivered quantities.

• Emergency Deliveries: May be required for urgent needs.

• Personnel & Security: Delivery personnel must comply with VA access and identification. All personnel handling radioactive materials must have appropriate training and licensing. Compliance with VA policies on patient privacy, facility access, and conduct is mandatory.

Solicitation / RFP / RFQ

This is a combined synopsis/solicitation (RFQ #: 36C25926R0074) for commercial items to procure Nuclear Medicine Radiopharmaceuticals for the Cheyenne VA Medical Center. The government anticipates awarding a firm-fixed-price Indefinite Delivery/Indefinite Quantity (IDIQ) contract.

• Recurring deliveries of Nuclear Medicine Radiopharmaceuticals to support Nuclear Medicine diagnostic exams.

• Daily, procedure-driven deliveries are required due to short half-lives and storage limitations.

• Contract minimum is $30,000 of Nuclear Radiopharmaceuticals.

• Delivery and acceptance are to be F.O.B Destination at the Cheyenne VA Medical Center Radiology Department.

• Contract Type: Firm-fixed-price IDIQ.

• Period of Performance: Five (5) years, with an ordering period from June 1, 2026, to May 31, 2031. Includes an option for up to 6 months of continued performance.

• Quotes must be submitted via email to barron.long@va.gov by 12:00 PM Local Mountain Time on May 18, 2026. Faxed or hand-carried quotes will not be accepted.

• The deadline for all questions is 12:00 PM Local Mountain Time on May 14, 2026. Questions must be submitted in writing and will be answered via solicitation amendment.

• Evaluation Factors: Technical capability/quality, Price, and Past Performance.

• Award will be made on an All or Nothing Basis to the most advantageous offer.

• Offerors must submit quotes in three volumes: Technical Capability, Price, and Past Performance.

• NAICS Code: 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1300 Employees.

• This solicitation is Unrestricted.

• Refer to Attachment 2 - Line Items - Nuclear Radiopharmaceuticals for pricing.

• Offerors must state if quoted items are available through existing Government-wide Acquisition Contracts (GWAC), GSA MAS, or VA-wide Acquisition Contracts.

• FAR 52.212-1 (Instructions to Offerors) and FAR 52.212-2 (Evaluation) apply.

• VAAR clauses are also incorporated by reference.

Form / Attachment / Pricing Sheet

This document is an Excel spreadsheet containing line items and estimated quantities for nuclear radiopharmaceuticals. It serves as a pricing sheet or a detailed breakdown of anticipated needs for the opportunity.

• Line Items: Details specific nuclear radiopharmaceuticals and related supplies/services (e.g., Xe133 Vials, MAA Kit, Sodium Pertechnetate Tc-99m, Delivery Charges, Survey Meter Calibration, Syringe shields).
• Estimated Quantities: Provides the projected number of units required for each line item.
• Unit of Measure: Specifies the unit for each item (e.g., EACH).
• Ordering Periods: The quantities are broken down across multiple ordering periods, spanning from June 1, 2026, to May 31, 2031.
• Pricing: While unit prices and estimated total prices are listed, all values are currently set to 0.0, indicating that pricing details are to be provided by bidders or will be finalized later.

This attachment is crucial for bidders as it outlines the specific products and services the government anticipates procuring. Bidders should use this document to understand the scope of potential orders, the types and quantities of radiopharmaceuticals needed, and the contract duration. The zeroed-out pricing fields indicate that bidders will need to provide their pricing for these items as part of their proposal or quote.